ALFRED ALTOMARI Insider Trading $AGRX AGILE THERAPEUTICS INC
Get free email notifications about insider trading for ALFRED ALTOMARI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALFRED ALTOMARI. ALFRED ALTOMARI is in INSMED Inc ($INSM) and Director in INSMED Inc ($INSM) and Chief Commercial Officer in BARRIER THERAPEUTICS INC ($BTRX) and Chief Operating Officer in BARRIER THERAPEUTICS INC ($BTRX) and Chairman & Chief Exec Officer in AGILE THERAPEUTICS INC ($AGRX) and Chairman & Chief Executive Off in AGILE THERAPEUTICS INC ($AGRX) and Chairman and Chief Executive O in AGILE THERAPEUTICS INC ($AGRX) and Chief Executive Officer in AGILE THERAPEUTICS INC ($AGRX) and Chief Executive Oficer in AGILE THERAPEUTICS INC ($AGRX) and Director in Recro Pharma, Inc. ($REPH) and Director in Baudax Bio, Inc. ($BXRX).
ALFRED ALTOMARI in AGILE THERAPEUTICS INC
Trading Symbol: AGRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALFRED ALTOMARI: Chairman & Chief Executive Off, Chairman and Chief Executive O, Chairman & Chief Exec Officer, Chief Executive Officer, Chief Executive Oficer
Holdings: 468,710 shares
Current Value: $1,110,843
Latest Transaction: Mar 23 2021
$AGRX Market Capitalization: $65.57M
$AGRX Previous Close: $2.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ALFRED ALTOMARI in AGILE THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGRX, BTRX, BXRX, INSM, REPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 2.00 | 12,500 | 25,030 | 468,710 | 456.2 K to 468.7 K (+2.74 %) |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.82 | 692,641 | 1,953,248 | 692,641 | |
Aug 20 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 1.76 | 94,599 | 166,494 | 0 | |
Aug 20 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 1.76 | 94,599 | 166,494 | 456,210 | 361.6 K to 456.2 K (+26.16 %) |
Jun 23 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 1.76 | 50,000 | 88,000 | 94,599 | |
Jun 23 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 1.76 | 50,000 | 88,000 | 361,611 | 311.6 K to 361.6 K (+16.05 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.71 | 16,541 | 11,744 | 0 | |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.71 | 16,541 | 11,744 | 0 | |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 2.71 | 10,000 | 27,100 | 311,611 | 301.6 K to 311.6 K (+3.32 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 2.71 | 10,000 | 27,100 | 311,611 | 301.6 K to 311.6 K (+3.32 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.71 | 16,541 | 11,744 | 301,611 | 285.1 K to 301.6 K (+5.80 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.71 | 16,541 | 11,744 | 301,611 | 285.1 K to 301.6 K (+5.80 %) |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.83 | 833,333 | 2,358,332 | 833,333 | |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Grant | A | 0.00 | 26,502 | 0 | 285,070 | 258.6 K to 285.1 K (+10.25 %) |
Jun 11 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 1.27 | 20,000 | 25,400 | 258,568 | 238.6 K to 258.6 K (+8.38 %) |
Mar 26 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 1.54 | 25,000 | 38,500 | 238,568 | 213.6 K to 238.6 K (+11.71 %) |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.50 | 154,400 | 386,000 | 154,400 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 0.84 | 540,900 | 454,356 | 540,900 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.00 | 35,314 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.00 | 35,314 | 0 | 213,568 | 178.3 K to 213.6 K (+19.81 %) |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 0.58 | 150,000 | 87,000 | 150,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 0.00 | 35,314 | 0 | 51,981 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 3.46 | 256,000 | 885,760 | 256,000 | |
Aug 28 2017 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chairman & Chief Ex ... | Buy | P | 3.34 | 10,000 | 33,400 | 161,587 | 151.6 K to 161.6 K (+6.60 %) |
May 12 2017 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chairman and Chief ... | Buy | P | 3.51 | 10,000 | 35,100 | 151,587 | 141.6 K to 151.6 K (+7.06 %) |
Apr 12 2017 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chairman & Chief Ex ... | Option Exercise | M | 1.76 | 30,000 | 52,800 | 144,599 | |
Apr 12 2017 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chairman & Chief Ex ... | Buy | M | 1.76 | 30,000 | 52,800 | 141,587 | 111.6 K to 141.6 K (+26.88 %) |
Jan 27 2017 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.26 | 240,000 | 542,400 | 240,000 | |
Feb 10 2016 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.00 | 16,666 | 0 | 33,334 | |
Feb 10 2016 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Feb 10 2016 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 5.93 | 100,000 | 593,000 | 100,000 | |
Feb 10 2016 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.00 | 16,666 | 0 | 94,920 | 78.3 K to 94.9 K (+21.30 %) |
Jun 03 2015 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 8.73 | 2,500 | 21,825 | 78,254 | 75.8 K to 78.3 K (+3.30 %) |
Mar 11 2015 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 1.76 | 17,500 | 30,800 | 174,599 | |
Mar 11 2015 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 1.76 | 17,500 | 30,800 | 75,754 | 58.3 K to 75.8 K (+30.04 %) |
Feb 23 2015 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Ofi ... | Option Exercise | A | 10.75 | 90,000 | 967,500 | 90,000 | |
Feb 23 2015 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Ofi ... | Option Exercise | A | 9.45 | 90,000 | 850,500 | 90,000 |
Page: 1